ESSA Pharma Inc., a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, is pleased to announce the results of the votes on matters considered at its annual general meeting of shareholders of the Company held on June 25, 2019 in Vancouver, British Columbia, Canada.
June 25, 2019
· 6 min read